{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:39:56Z","timestamp":1785893996095,"version":"3.56.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the project of Nantong Natural Science Foundation","award":["JC2023042"],"award-info":[{"award-number":["JC2023042"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81872875"],"award-info":[{"award-number":["81872875"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Synaptic dysfunction, which occurs before the formation of amyloid plaques (A\u03b2) and neurofibrillary tangles (NFTs), is strongly associated with cognitive deficits and represents major early clinical features of Alzheimer\u2019s disease (AD). Abnormal NMDAR signaling emerges as a noticeable feature of synaptic dysfunctions in AD. Nonetheless, the underlying mechanisms of NMDAR dysfunctions remain unclear.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>3xTg-AD mice were injected with AAV-IRF1. Cognitive function was assessed using behavioral tests, while biochemical and immunofluorescence analyses were conducted to evaluate the protein levels of IRF-1, OGA, subunits of NMDAR, O-GlcNAcylation of NMDAR subunits, and internalization of NMDA receptors. Synaptic alterations in the hippocampus were detected by electrophysiology and Golgi staining.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In the present study, we demonstrate that Interferon Regulatory Factor-1 (IRF-1), which is deficient in the brain of individuals with Alzheimer\u2019s disease (AD), negatively regulates the O-GlcNAcylation levels of GluN1 through transcriptional regulation of the human OGA gene. Furthermore, IRF-1 may influence trafficking of NMDARs, thereby affecting dendritic spine density and synaptic plasticity, and ultimately improving the learning and memory of 3xTg-AD mice.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Our results indicate that IRF1 can improve the cognitive function of 3xTg-AD mice by regulating the O-GlcNAcylation of GluN1, offering evidence that IRF-1 could serve as a novel therapeutic target for treating synaptic dysfunction in Alzheimer\u2019s diseases.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13195-025-01857-w","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T10:21:39Z","timestamp":1759227699000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["IRF1 ameliorates synaptic dysfunction through the modulation of O-GlcNAcylation on GluN1 subunit of NMDAR"],"prefix":"10.1186","volume":"17","author":[{"given":"Xing","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuiping","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijia","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liye","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"key":"1857_CR1","doi-asserted-by":"crossref","unstructured":"2023 Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s & Dementia. 2023;19:1598\u20131695.","DOI":"10.1002\/alz.13016"},{"key":"1857_CR2","doi-asserted-by":"publisher","first-page":"e933084","DOI":"10.12659\/MSM.933084","volume":"27","author":"X Yin","year":"2021","unstructured":"Yin X, Qiu Y, Zhao C, Zhou Z, Bao J, Qian W. The role of amyloid-beta and tau in the early pathogenesis of Alzheimer\u2019s disease. Med Sci Monit. 2021;27:e933084.","journal-title":"Med Sci Monit"},{"key":"1857_CR3","doi-asserted-by":"publisher","first-page":"671779","DOI":"10.3389\/fnmol.2021.671779","volume":"14","author":"X Yin","year":"2021","unstructured":"Yin X, Zhao C, Qiu Y, Zhou Z, Bao J, Qian W. Dendritic\/post-synaptic tau and early pathology of Alzheimer\u2019s disease. Front Mol Neurosci. 2021;14:671779.","journal-title":"Front Mol Neurosci"},{"key":"1857_CR4","doi-asserted-by":"crossref","unstructured":"Jackson J, Jambrina E, Li J, Marston H, Menzies F, Phillips K, Gilmour G. Targeting the synapse in Alzheimer\u2019s disease. Front NeuroSci. 2019;13.","DOI":"10.3389\/fnins.2019.00735"},{"key":"1857_CR5","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1038\/s41380-022-01565-z","volume":"27","author":"L Peng","year":"2022","unstructured":"Peng L, Bestard-Lorigados I, Song W. The synapse as a treatment avenue for Alzheimer\u2019s disease. Mol Psychiatry. 2022;27:2940\u20139.","journal-title":"Mol Psychiatry"},{"key":"1857_CR6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1146\/annurev-neuro-090919-022842","volume":"43","author":"JC Magee","year":"2020","unstructured":"Magee JC, Grienberger C. Synaptic plasticity forms and functions. Annu Rev Neurosci. 2020;43:95\u2013117.","journal-title":"Annu Rev Neurosci"},{"key":"1857_CR7","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/s41591-019-0375-9","volume":"25","author":"EP Moreno-Jim\u00e9nez","year":"2019","unstructured":"Moreno-Jim\u00e9nez EP, Flor-Garc\u00eda M, Terreros-Roncal J, R\u00e1bano A, Cafini F, Pallas-Bazarra N, \u00c1vila J, Llorens-Mart\u00edn M. Adult hippocampal neurogenesis is abundant in neurologically healthy subjects and drops sharply in patients with Alzheimer\u2019s disease. Nat Med. 2019;25:554\u201360.","journal-title":"Nat Med"},{"key":"1857_CR8","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/nature13294","volume":"511","author":"S Nabavi","year":"2014","unstructured":"Nabavi S, Fox R, Proulx CD, Lin JY, Tsien RY, Malinow R. Engineering a memory with LTD and LTP. Nature. 2014;511:348\u201352.","journal-title":"Nature"},{"key":"1857_CR9","doi-asserted-by":"publisher","first-page":"1059730","DOI":"10.3389\/fnmol.2023.1059730","volume":"16","author":"CR Zaccard","year":"2023","unstructured":"Zaccard CR, Gippo I, Song A, Geula C, Penzes P. Dendritic spinule-mediated structural synaptic plasticity: implications for development, aging, and psychiatric disease. Front Mol Neurosci. 2023;16:1059730.","journal-title":"Front Mol Neurosci"},{"key":"1857_CR10","doi-asserted-by":"publisher","first-page":"15822","DOI":"10.1021\/acs.chemrev.1c01006","volume":"122","author":"J Ma","year":"2022","unstructured":"Ma J, Hou C, Wu C. Demystifying the O-GlcNAc code: a systems view. Chem Rev. 2022;122:15822\u201364.","journal-title":"Chem Rev"},{"key":"1857_CR11","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1093\/glycob\/cwy031","volume":"28","author":"J Shi","year":"2018","unstructured":"Shi J, Ruijtenbeek R, Pieters RJ. Demystifying O-GlcNAcylation: hints from peptide substrates. Glycobiology. 2018;28:814\u201324.","journal-title":"Glycobiology"},{"key":"1857_CR12","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1007\/s00726-014-1827-7","volume":"46","author":"AK Nagel","year":"2014","unstructured":"Nagel AK, Ball LE. O-GlcNAc transferase and O-GlcNAcase: achieving target substrate specificity. Amino Acids. 2014;46:2305\u201316.","journal-title":"Amino Acids"},{"key":"1857_CR13","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1038\/onc.2010.41","volume":"29","author":"SA Caldwell","year":"2010","unstructured":"Caldwell SA, Jackson SR, Shahriari KS, Lynch TP, Sethi G, Walker S, Vosseller K, Reginato MJ. Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1. Oncogene. 2010;29:2831\u201342.","journal-title":"Oncogene"},{"key":"1857_CR14","doi-asserted-by":"publisher","first-page":"6050","DOI":"10.1073\/pnas.1424017112","volume":"112","author":"PS Banerjee","year":"2015","unstructured":"Banerjee PS, Ma J, Hart GW. Diabetes-associated dysregulation of O-GlcNAcylation in rat cardiac mitochondria. Proc Natl Acad Sci. 2015;112:6050\u20135.","journal-title":"Proc Natl Acad Sci"},{"key":"1857_CR15","doi-asserted-by":"publisher","first-page":"10804","DOI":"10.1073\/pnas.0400348101","volume":"101","author":"F Liu","year":"2004","unstructured":"Liu F, Iqbal K, Grundke-Iqbal I, Hart GW, Gong C-X. O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 2004;101:10804\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1857_CR16","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1046\/j.1471-4159.2003.01939.x","volume":"86","author":"R Okuyama","year":"2003","unstructured":"Okuyama R, Marshall S. UDP-N-acetylglucosaminyl transferase (OGT) in brain tissue: temperature sensitivity and subcellular distribution of cytosolic and nuclear enzyme. J Neurochem. 2003;86:1271\u201380.","journal-title":"J Neurochem"},{"key":"1857_CR17","doi-asserted-by":"publisher","first-page":"9838","DOI":"10.1074\/jbc.M010420200","volume":"276","author":"Y Gao","year":"2001","unstructured":"Gao Y, Wells L, Comer FI, Parker GJ, Hart GW. Dynamic O-glycosylation of nuclear and cytosolic proteins. J Biol Chem. 2001;276:9838\u201345.","journal-title":"J Biol Chem"},{"key":"1857_CR18","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1046\/j.1471-4159.2001.00655.x","volume":"79","author":"RN Cole","year":"2001","unstructured":"Cole RN, Hart GW. Cytosolic O-glycosylation is abundant in nerve terminals. J Neurochem. 2001;79:1080\u20139.","journal-title":"J Neurochem"},{"key":"1857_CR19","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1038\/s12276-021-00709-5","volume":"53","author":"BE Lee","year":"2021","unstructured":"Lee BE, Suh P-G, Kim J-I. O-GlcNAcylation in health and neurodegenerative diseases. Exp Mol Med. 2021;53:1674\u201382.","journal-title":"Exp Mol Med"},{"key":"1857_CR20","doi-asserted-by":"crossref","unstructured":"Alfaro JF, Gong C-X, Monroe ME, Aldrich JT, Clauss TRW, Purvine SO, Wang Z, Camp DG, Shabanowitz J, Stanley P et al. Tandem mass spectrometry identifies many mouse brain O-GlcNAcylated proteins including EGF domain-specific O-GlcNAc transferase targets. Proc Natl Acad Sci. 2012;109:7280\u20137285.","DOI":"10.1073\/pnas.1200425109"},{"key":"1857_CR21","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/path.4929","volume":"243","author":"S Wang","year":"2017","unstructured":"Wang S, Yang F, Petyuk VA, Shukla AK, Monroe ME, Gritsenko MA, Rodland KD, Smith RD, Qian WJ, Gong CX, Liu T. Quantitative proteomics identifies altered O-GlcNAcylation of structural, synaptic and memory\u2010associated proteins in Alzheimer\u2019s disease. J Pathol. 2017;243:78\u201388.","journal-title":"J Pathol"},{"key":"1857_CR22","doi-asserted-by":"publisher","first-page":"6076","DOI":"10.1074\/jbc.M116.774042","volume":"292","author":"S Olivier-Van Stichelen","year":"2017","unstructured":"Olivier-Van Stichelen S, Wang P, Comly M, Love DC, Hanover JA. Nutrient-driven O-linked N-acetylglucosamine (O-GlcNAc) cycling impacts neurodevelopmental timing and metabolism. J Biol Chem. 2017;292:6076\u201385.","journal-title":"J Biol Chem"},{"key":"1857_CR23","doi-asserted-by":"publisher","first-page":"44921","DOI":"10.1038\/srep44921","volume":"7","author":"Y Yang","year":"2017","unstructured":"Yang Y, Song S, Hwang H, Jung J, Kim S, Yoon S, Hur J, Park J, Lee C, Nam D, et al. Memory and synaptic plasticity are impaired by dysregulated hippocampal O-GlcNAcylation. Sci Rep. 2017;7:44921.","journal-title":"Sci Rep"},{"key":"1857_CR24","doi-asserted-by":"publisher","first-page":"8636","DOI":"10.1074\/jbc.RA119.010312","volume":"295","author":"V Muha","year":"2020","unstructured":"Muha V, Fenckova M, Ferenbach AT, Catinozzi M, Eidhof I, Storkebaum E, Schenck A, van Aalten DMF. O-GlcNAcase contributes to cognitive function in drosophila. J Biol Chem. 2020;295:8636\u201346.","journal-title":"J Biol Chem"},{"key":"1857_CR25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1146\/annurev.ne.17.030194.000335","volume":"17","author":"M Hollmann","year":"1994","unstructured":"Hollmann M, Heinemann S. Cloned glutamate receptors. Annu Rev Neurosci. 1994;17:31\u2013108.","journal-title":"Annu Rev Neurosci"},{"key":"1857_CR26","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1002\/hipo.20950","volume":"22","author":"Y Shinohara","year":"2012","unstructured":"Shinohara Y. Quantification of postsynaptic density proteins: glutamate receptor subunits and scaffolding proteins. Hippocampus. 2012;22:942\u201353.","journal-title":"Hippocampus"},{"key":"1857_CR27","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1523\/JNEUROSCI.4761-12.2014","volume":"34","author":"EW Taylor","year":"2013","unstructured":"Taylor EW, Wang K, Nelson AR, Bredemann TM, Fraser KB, Clinton SM, Puckett R, Marchase RB, Chatham JC, McMahon LL. O-GlcNAcylation of AMPA receptor GluA2 is associated with a novel form of long-term depression at hippocampal synapses. J Neurosci. 2013;34:10\u201321.","journal-title":"J Neurosci"},{"key":"1857_CR28","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S0959-4388(00)00215-4","volume":"11","author":"SBS Cull-Candy","year":"2001","unstructured":"Cull-Candy SBS, Farrant M. NMDA receptor subunits: diversity, development and disease. Curr Opin Neurobiol. 2001;11:327\u201335.","journal-title":"Curr Opin Neurobiol"},{"key":"1857_CR29","doi-asserted-by":"crossref","unstructured":"Ladagu AD, Olopade FE, Adejare A, Olopade JO. GluN2A and GluN2B N-Methyl-D-Aspartate receptor (NMDARs) subunits: their roles and therapeutic antagonists in neurological diseases. Pharmaceuticals. 2023;16.","DOI":"10.3390\/ph16111535"},{"key":"1857_CR30","doi-asserted-by":"crossref","unstructured":"Monyer HBN, Laurie DJ, Sakmann B, Seeburg PH. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. 1994.","DOI":"10.1016\/0896-6273(94)90210-0"},{"key":"1857_CR31","doi-asserted-by":"publisher","first-page":"a005710","DOI":"10.1101\/cshperspect.a005710","volume":"4","author":"C Luscher","year":"2012","unstructured":"Luscher C, Malenka RC. NMDA receptor-dependent long-term potentiation and long-term depression (LTP\/LTD). Cold Spring Harb Perspect Biol. 2012;4:a005710\u2013005710.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"1857_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.fct.2018.01.023","volume":"113","author":"X Hu","year":"2018","unstructured":"Hu X, Yang J, Sun Y, Gao X, Zhang L, Li Y, Yu M, Liu S, Lu X, Jin C, et al. Lanthanum chloride impairs memory in rats by disturbing the glutamate-glutamine cycle and over-activating NMDA receptors. Food Chem Toxicol. 2018;113:1\u201313.","journal-title":"Food Chem Toxicol"},{"key":"1857_CR33","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S0092-8674(88)91307-4","volume":"54","author":"M Miyamoto","year":"1988","unstructured":"Miyamoto M, Fujita T, Kimura Y, Maruyama M, Harada H, Sudo Y, Miyata T, Taniguchi T. Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-beta gene regulatory elements. Cell. 1988;54:903\u201313.","journal-title":"Cell"},{"key":"1857_CR34","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/34224","volume":"391","author":"C Escalante","year":"1998","unstructured":"Escalante C, Yie J, Thanos D, Aggarwal A. Structure of IRF-1 with bound DNA reveals determinants of interferon regulation. Nature. 1998;391:103\u20136.","journal-title":"Nature"},{"key":"1857_CR35","doi-asserted-by":"publisher","first-page":"H408","DOI":"10.1152\/ajpheart.00411.2018","volume":"316","author":"X Fan","year":"2019","unstructured":"Fan X, Chen X, Feng Q, Peng K, Wu Q, Passerini AG, Simon SI, Sun C. Downregulation of GATA6 in mTOR-inhibited human aortic endothelial cells: effects on TNF-\u03b1-induced VCAM-1 expression and monocytic cell adhesion. Am J Physiol Heart Circ Physiol. 2019;316:H408\u201320.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1857_CR36","doi-asserted-by":"crossref","unstructured":"Fan X, Li Q, Wang Y, Zhang DM, Zhou J, Chen Q, Sheng L, Passerini AG, Sun C. Non-canonical NF-kappaB contributes to endothelial pyroptosis and atherogenesis dependent on IRF-1. Transl Res. 2023;255:1-13.","DOI":"10.1016\/j.trsl.2022.11.001"},{"key":"1857_CR37","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.yjmcc.2020.02.006","volume":"140","author":"K Peng","year":"2020","unstructured":"Peng K, Fan X, Li Q, Wang Y, Chen X, Xiao P, Passerini AG, Simon SI, Sun C. IRF-1 mediates the suppressive effects of mTOR inhibition on arterial endothelium. J Mol Cell Cardiol. 2020;140:30\u201341.","journal-title":"J Mol Cell Cardiol"},{"key":"1857_CR38","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1161\/CIRCRESAHA.112.270314","volume":"111","author":"C Sun","year":"2012","unstructured":"Sun C, Alkhoury K, Wang YI, Foster GA, Radecke CE, Tam K, Edwards CM, Facciotti MT, Armstrong EJ, Knowlton AA, et al. IRF-1 and miRNA126 modulate VCAM-1 expression in response to a high-fat meal. Circ Res. 2012;111:1054\u201364.","journal-title":"Circ Res"},{"key":"1857_CR39","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/s41440-018-0080-y","volume":"41","author":"M Mogi","year":"2018","unstructured":"Mogi M, Iwanami J, Wang X, Tsukuda K, Kan-No H, Bai H, Shan B, Higaki A, Min L, Horiuchi M. Deletion of interferon-regulatory factor-1 results in cognitive impairment. Hypertens Research: Official J Japanese Soc Hypertens. 2018;41:809\u201316.","journal-title":"Hypertens Research: Official J Japanese Soc Hypertens"},{"key":"1857_CR40","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/jcbfm.2011.133","volume":"32","author":"F Jing","year":"2012","unstructured":"Jing F, Mogi M, Sakata A, Iwanami J, Tsukuda K, Ohshima K, Min L, Steckelings U, Unger T, Dahl\u00f6f B, Horiuchi M. Direct stimulation of angiotensin II type 2 receptor enhances spatial memory. J Cereb Blood Flow Metabolism: Official J Int Soc Cereb Blood Flow Metabolism. 2012;32:248\u201355.","journal-title":"J Cereb Blood Flow Metabolism: Official J Int Soc Cereb Blood Flow Metabolism"},{"key":"1857_CR41","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1161\/01.RES.86.2.233","volume":"86","author":"M Horiuchi","year":"2000","unstructured":"Horiuchi M, Hayashida W, Akishita M, Yamada S, Lehtonen J, Tamura K, Daviet L, Chen Y, Hamai M, Cui T, et al. Interferon-gamma induces AT(2) receptor expression in fibroblasts by jak\/stat pathway and interferon regulatory factor-1. Circul Res. 2000;86:233\u201340.","journal-title":"Circul Res"},{"key":"1857_CR42","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1007\/s11481-012-9345-4","volume":"7","author":"B Gelman","year":"2012","unstructured":"Gelman B, Lisinicchia J, Chen T, Johnson K, Jennings K, Freeman D, Soukup V. Prefrontal dopaminergic and enkephalinergic synaptic accommodation in HIV-associated neurocognitive disorders and encephalitis. J Neuroimmune Pharmacology: Official J Soc NeuroImmune Pharmacol. 2012;7:686\u2013700.","journal-title":"J Neuroimmune Pharmacology: Official J Soc NeuroImmune Pharmacol"},{"key":"1857_CR43","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","volume":"39","author":"S Oddo","year":"2003","unstructured":"Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM. Triple-transgenic model of alzheimer\u2019s disease with plaques and tangles. Neuron. 2003;39:409\u201321.","journal-title":"Neuron"},{"key":"1857_CR44","doi-asserted-by":"publisher","first-page":"4323","DOI":"10.1038\/s41380-022-01689-2","volume":"27","author":"X Yin","year":"2022","unstructured":"Yin X, Li Y, Fan X, Huang F, Qiu Y, Zhao C, Zhou Z, Gu Q, Xia L, Bao J, et al. SIRT1 deficiency increases O-GlcNAcylation of tau, mediating synaptic tauopathy. Mol Psychiatry. 2022;27:4323\u201334.","journal-title":"Mol Psychiatry"},{"key":"1857_CR45","doi-asserted-by":"crossref","unstructured":"Takeuchi T, Duszkiewicz AJ, Morris RGM. The synaptic plasticity and memory hypothesis: encoding, storage and persistence. Philosophical Trans Royal Soc B: Biol Sci. 2014;369.","DOI":"10.1098\/rstb.2013.0288"},{"key":"1857_CR46","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/nrn.2016.68","volume":"17","author":"TVP Bliss","year":"2016","unstructured":"Bliss TVP, Collingridge GL, Kaang B-K, Zhuo M. Synaptic plasticity in the anterior cingulate cortex in acute and chronic pain. Nat Rev Neurosci. 2016;17:485\u201396.","journal-title":"Nat Rev Neurosci"},{"key":"1857_CR47","doi-asserted-by":"crossref","unstructured":"Cull-Candy SGLD. Role of distinct NMDA receptor subtypes at central synapses. 2004.","DOI":"10.1126\/stke.2552004re16"},{"key":"1857_CR48","doi-asserted-by":"crossref","unstructured":"Zhuo M. Plasticity of NMDA receptor NR2B subunit in memory and chronic pain. Mol Brain. 2009;2.","DOI":"10.1186\/1756-6606-2-4"},{"key":"1857_CR49","doi-asserted-by":"crossref","unstructured":"Zhuo M. Long-term potentiation in the anterior cingulate cortex and chronic pain. Philosophical Trans Royal Soc B: Biol Sci. 2014;369.","DOI":"10.1098\/rstb.2013.0146"},{"key":"1857_CR50","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41582-022-00749-z","volume":"19","author":"M Tzioras","year":"2022","unstructured":"Tzioras M, McGeachan RI, Durrant CS, Spires-Jones TL. Synaptic degeneration in alzheimer disease. Nat Reviews Neurol. 2022;19:19\u201338.","journal-title":"Nat Reviews Neurol"},{"key":"1857_CR51","doi-asserted-by":"publisher","first-page":"28596","DOI":"10.1074\/jbc.R115.652750","volume":"290","author":"MP Lussier","year":"2015","unstructured":"Lussier MP, Sanz-Clemente A, Roche KW. Dynamic regulation of N-Methyl-d-aspartate (NMDA) and \u03b1-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors by posttranslational modifications. J Biol Chem. 2015;290:28596\u2013603.","journal-title":"J Biol Chem"},{"key":"1857_CR52","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.semcdb.2011.06.003","volume":"22","author":"S Qiu","year":"2011","unstructured":"Qiu S, Li X-Y, Zhuo M. Post-translational modification of NMDA receptor GluN2B subunit and its roles in chronic pain and memory. Semin Cell Dev Biol. 2011;22:521\u20139.","journal-title":"Semin Cell Dev Biol"},{"key":"1857_CR53","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1074\/mcp.T500040-MCP200","volume":"5","author":"K Vosseller","year":"2006","unstructured":"Vosseller K, Trinidad JC, Chalkley RJ, Specht CG, Thalhammer A, Lynn AJ, Snedecor JO, Guan S, Medzihradszky KF, Maltby DA, et al. O-Linked N-Acetylglucosamine proteomics of postsynaptic density preparations using lectin weak affinity chromatography and mass spectrometry. Mol Cell Proteom. 2006;5:923\u201334.","journal-title":"Mol Cell Proteom"},{"key":"1857_CR54","unstructured":"Khidekel NFS, Peters EC, Hsieh-Wilson LC. Exploring the O-GlcNAc proteome: direct identification of O-GlcNAc-modified proteins from the brain. 2004."},{"key":"1857_CR55","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1074\/mcp.O112.018366","volume":"11","author":"JC Trinidad","year":"2012","unstructured":"Trinidad JC, Barkan DT, Gulledge BF, Thalhammer A, Sali A, Schoepfer R, Burlingame AL. Global identification and characterization of both O-GlcNAcylation and phosphorylation at the murine synapse. Mol Cell Proteom. 2012;11:215\u201329.","journal-title":"Mol Cell Proteom"},{"key":"1857_CR56","doi-asserted-by":"crossref","unstructured":"Chalkley RJTA, Schoepfer R, Burlingame AL. Identification of protein O-GlcNAcylation sites using electron transfer dissociation mass spectrometry on native peptides. Proc Natl Acad Sci U S A. 2009;106(22):8894-8899.","DOI":"10.1073\/pnas.0900288106"},{"key":"1857_CR57","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1007\/s11064-010-0135-1","volume":"35","author":"T Kanno","year":"2010","unstructured":"Kanno T, Yaguchi T, Nagata T, Mukasa T, Nishizaki T. Regulation of AMPA receptor trafficking by O-Glycosylation. Neurochem Res. 2010;35:782\u20138.","journal-title":"Neurochem Res"},{"key":"1857_CR58","doi-asserted-by":"crossref","unstructured":"Taniguchi TOK, Takaoka A, Tanaka N. IRF family of transcription factors as regulators of host defense. 2001.","DOI":"10.1146\/annurev.immunol.19.1.623"},{"key":"1857_CR59","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1007\/s00401-002-0658-x","volume":"105","author":"M Alexander","year":"2002","unstructured":"Alexander M, Forster C, Sugimoto K, Clark HB, Vogel S, Ross ME, Iadecola C. Interferon regulatory factor-1 immunoreactivity in neurons and inflammatory cells following ischemic stroke in rodents and humans. Acta Neuropathol. 2002;105:420\u20134.","journal-title":"Acta Neuropathol"},{"key":"1857_CR60","doi-asserted-by":"crossref","unstructured":"Tada YHA, Matsuyama T, Mak TW. Reduced incidence and severity of antigen-induced autoimmune diseases in mice lacking interferon regulatory factor-1. J Exp Med. 1997;185(2):231-238.","DOI":"10.1084\/jem.185.2.231"},{"key":"1857_CR61","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jneuroim.2011.01.001","volume":"233","author":"Z Ren","year":"2011","unstructured":"Ren Z, Wang Y, Liebenson D, Liggett T, Goswami R, Stefoski D, Balabanov R. IRF-1 signaling in central nervous system glial cells regulates inflammatory demyelination. J Neuroimmunol. 2011;233:147\u201359.","journal-title":"J Neuroimmunol"},{"key":"1857_CR62","doi-asserted-by":"publisher","first-page":"8329","DOI":"10.1523\/JNEUROSCI.1028-11.2011","volume":"31","author":"Z Ren","year":"2011","unstructured":"Ren Z, Wang Y, Tao D, Liebenson D, Liggett T, Goswami R, Clarke R, Stefoski D, Balabanov R. Overexpression of the dominant-negative form of interferon regulatory factor 1 in oligodendrocytes protects against experimental autoimmune encephalomyelitis. J Neurosci. 2011;31:8329\u201341.","journal-title":"J Neurosci"},{"key":"1857_CR63","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/s11481-010-9193-z","volume":"5","author":"Z Ren","year":"2010","unstructured":"Ren Z, Wang Y, Tao D, Liebenson D, Liggett T, Goswami R, Stefoski D, Balabanov R. Central nervous system expression of interferon regulatory factor 1 regulates experimental autoimmune encephalomyelitis. J Neuroimmune Pharmacol. 2010;5:260\u20135.","journal-title":"J Neuroimmune Pharmacol"},{"key":"1857_CR64","doi-asserted-by":"crossref","unstructured":"Hwang H, Rhim H. Acutely elevated O-GlcNAcylation suppresses hippocampal activity by modulating both intrinsic and synaptic excitability factors. Sci Rep. 2019;9.","DOI":"10.1038\/s41598-019-43017-9"},{"key":"1857_CR65","doi-asserted-by":"crossref","unstructured":"Planel E, Liu Y, Li X, Yu Y, Shi J, Liang Z, Run X, Li Y, Dai C-l, Grundke-Iqbal I et al. Developmental regulation of protein O-GlcNAcylation, O-GlcNAc transferase, and O-GlcNAcase in mammalian brain. PLoS ONE. 2012;7.","DOI":"10.1371\/journal.pone.0043724"},{"key":"1857_CR66","first-page":"4531","volume":"13","author":"N Tanaka","year":"1993","unstructured":"Tanaka N, Kawakami T, Taniguchi T. Recognition DNA sequences of interferon regulatory factor 1 (IRF-1) and IRF-2, regulators of cell growth and the interferon system. Mol Cell Biol. 1993;13:4531\u20138.","journal-title":"Mol Cell Biol"},{"key":"1857_CR67","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1101\/sqb.2013.78.020321","volume":"78","author":"H Ikushima","year":"2013","unstructured":"Ikushima H, Negishi H, Taniguchi T. The IRF family transcription factors at the interface of innate and adaptive immune responses. Cold Spring Harb Symp Quant Biol. 2013;78:105\u201316.","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"1857_CR68","doi-asserted-by":"crossref","unstructured":"Lin Z, Wang J, Zhang N, Yi J, Wang Z, Ma J, Wang H, Yan Y, Qian K, Sun J, Cheng Y. Functional characterization of Goose IRF1 in IFN induction and anti-NDV infection. Vet Res. 2022;53.","DOI":"10.1186\/s13567-022-01046-9"},{"key":"1857_CR69","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nchembio.797","volume":"8","author":"SA Yuzwa","year":"2012","unstructured":"Yuzwa SA, Shan X, Macauley MS, Clark T, Skorobogatko Y, Vosseller K, Vocadlo DJ. Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation. Nat Chem Biol. 2012;8:393\u20139.","journal-title":"Nat Chem Biol"},{"key":"1857_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14737175.2019.1540932","volume":"19","author":"F Di Domenico","year":"2018","unstructured":"Di Domenico F, Lanzillotta C, Tramutola A. Therapeutic potential of rescuing protein O-GlcNAcylation in tau-related pathologies. Expert Rev Neurother. 2018;19:1\u20133.","journal-title":"Expert Rev Neurother"},{"key":"1857_CR71","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/j.bbadis.2014.05.014","volume":"1842","author":"S F\u00f6rster","year":"2014","unstructured":"F\u00f6rster S, Welleford AS, Triplett JC, Sultana R, Schmitz B, Butterfield DA. Increased O-GlcNAc levels correlate with decreased O-GlcNAcase levels in alzheimer disease brain. Biochim Et Biophys Acta (BBA) - Mol Basis Disease. 2014;1842:1333\u20139.","journal-title":"Biochim Et Biophys Acta (BBA) - Mol Basis Disease"},{"key":"1857_CR72","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.neuropharm.2013.11.025","volume":"79","author":"DL Graham","year":"2014","unstructured":"Graham DL, Gray AJ, Joyce JA, Yu D, O\u2019Moore J, Carlson GA, Shearman MS, Dellovade TL, Hering H. Increased O-GlcNAcylation reduces pathological tau without affecting its normal phosphorylation in a mouse model of tauopathy. Neuropharmacology. 2014;79:307\u201313.","journal-title":"Neuropharmacology"},{"key":"1857_CR73","doi-asserted-by":"crossref","unstructured":"Wang AC, Jensen EH, Rexach JE, Vinters HV, Hsieh-Wilson LC. Loss of O-GlcNAc glycosylation in forebrain excitatory neurons induces neurodegeneration. Proc Natl Acad Sci. 2016;113:15120\u201315125.","DOI":"10.1073\/pnas.1606899113"},{"key":"1857_CR74","doi-asserted-by":"crossref","unstructured":"Yu Y, Zhang L, Li X, Run X, Liang Z, Li Y, Liu Y, Lee MH, Grundke-Iqbal I, Iqbal K et al. Differential effects of an O-GlcNAcase inhibitor on Tau phosphorylation. PLoS ONE. 2012;7.","DOI":"10.1371\/journal.pone.0035277"},{"key":"1857_CR75","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1006\/bbrc.1995.2149","volume":"213","author":"LS Griffith","year":"1995","unstructured":"Griffith LS, Schmitz B. O-linked N-acetylglucosamine is upregulated in alzheimer brains. Biochem Biophys Res Commun. 1995;213:424\u201331.","journal-title":"Biochem Biophys Res Commun"},{"key":"1857_CR76","doi-asserted-by":"crossref","unstructured":"Kim DY, Kim S-M, Han I-O. Chronic rapid eye movement sleep deprivation aggravates the pathogenesis of Alzheimer\u2019s disease by decreasing brain O-GlcNAc cycling in mice. J Neuroinflamm. 2024;21.","DOI":"10.1186\/s12974-024-03179-4"},{"key":"1857_CR77","doi-asserted-by":"crossref","unstructured":"Wang P, Lazarus BD, Forsythe ME, Love DC, Krause MW, Hanover JA. O-GlcNAc cycling mutants modulate proteotoxicity in Caenorhabditis elegans models of human neurodegenerative diseases. Proc Natl Acad Sci. 2012;109:17669\u201317674.","DOI":"10.1073\/pnas.1205748109"},{"key":"1857_CR78","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nrn3504","volume":"14","author":"P Paoletti","year":"2013","unstructured":"Paoletti P, Bellone C, Zhou Q. NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease. Nat Rev Neurosci. 2013;14:383\u2013400.","journal-title":"Nat Rev Neurosci"},{"key":"1857_CR79","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1016\/j.neuron.2023.05.002","volume":"111","author":"JP Dupuis","year":"2023","unstructured":"Dupuis JP, Nicole O, Groc L. NMDA receptor functions in health and disease: old actor, new dimensions. Neuron. 2023;111:2312\u201328.","journal-title":"Neuron"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01857-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-025-01857-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01857-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T23:29:12Z","timestamp":1759274952000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-025-01857-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1857"],"URL":"https:\/\/doi.org\/10.1186\/s13195-025-01857-w","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"26 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"205"}}